Per Digiday, companies like Opella are borrowing from FMCG (fast-moving consumer goods) media buying strategies to pivot healthcare marketing around shifting consumer health habits, raising questions about whether healthcare brands can adopt FMCG tactics without inheriting the same fragmentation or regulatory friction.
ReadingThe steal: this is not a tactic — it is a permission shift. Healthcare brands have historically over-indexed on precision and compliance; FMCG brands over-index on velocity and share of voice. Opella's move says: you can compress healthcare messaging into shorter, simpler, more frequent touches and still convert. For a consumer health brand (vitamins, OTC, wellness): adopt FMCG media allocation (40% TV/linear, 30% social/streaming, 20% retail media, 10% test). Buy frequency, not precision. Reduce claim density — say one thing, say it repeatedly, say it in five channels. This contradicts healthcare's usual playbook (longer copy, more claims, fewer placements). Test this model on one sub-category (e.g., probiotics vs. full portfolio), measure NPS + repeat purchase, and scale if retention holds.
MY STASH TAKEHealthcare has always been held to a higher standard than FMCG, and for good reason. But Opella is signaling that the audience (regular consumers, not patients in crisis) now expects shorter, snappier health messaging. They want to see the brand in five places, not one authoritative whitepaper. This is a real trend, not a theory. For any CPG brand with a wellness or health angle, this is permission to compress your message and increase frequency. Short claims, multiple channels, repeat. Track repeat purchase rate (the real signal of trust) and you'll see if the FMCG model works for you.
WatchWatch Digiday and Ad Age for case studies on Opella's 2027 campaign performance — regulatory outcomes will matter.